1. Home
  2. CTSH vs KVUE Comparison

CTSH vs KVUE Comparison

Compare CTSH & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cognizant Technology Solutions Corporation

CTSH

Cognizant Technology Solutions Corporation

HOLD

Current Price

$83.49

Market Cap

35.3B

Sector

Technology

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.36

Market Cap

39.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSH
KVUE
Founded
1994
2022
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Specialty Chemicals
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
35.3B
39.9B
IPO Year
1998
2023

Fundamental Metrics

Financial Performance
Metric
CTSH
KVUE
Price
$83.49
$17.36
Analyst Decision
Buy
Buy
Analyst Count
17
13
Target Price
$86.07
$20.31
AVG Volume (30 Days)
4.1M
37.0M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
1.48%
4.79%
EPS Growth
N/A
35.31
EPS
4.32
0.75
Revenue
$20,857,000,000.00
$15,006,000,000.00
Revenue This Year
$8.96
N/A
Revenue Next Year
$4.72
$2.81
P/E Ratio
$19.43
$23.18
Revenue Growth
7.44
N/A
52 Week Low
$65.15
$14.02
52 Week High
$90.82
$25.17

Technical Indicators

Market Signals
Indicator
CTSH
KVUE
Relative Strength Index (RSI) 81.36 60.90
Support Level $79.43 $16.70
Resistance Level $84.24 $17.59
Average True Range (ATR) 1.55 0.31
MACD 0.53 0.03
Stochastic Oscillator 96.63 76.29

Price Performance

Historical Comparison
CTSH
KVUE

About CTSH Cognizant Technology Solutions Corporation

Cognizant Technology Solutions is a multinational IT services provider that offers a range of consulting and business process outsourcing services. Originally founded in India, the company is headquartered in the US and serves enterprise customers spanning the financial services, healthcare, and resources industries. With most of its workforce located in India, Cognizant leverages a global delivery model that helps clients outsource their IT needs to offshore labor.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: